Physician profile
Echo Tan
NPI 1427373323
$95,141.22
in general payments reported to CMS, 2019-2025
13 companies · $16K in 2025
The $16K reported for 2025 was more than what 92% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $75.38 · 2020: $8,136 · 2021: $25K · 2022: $14K · 2023: $27K · 2024: $4,294 · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $41K · Consulting Fee: $2,775 · Travel and Lodging: $2,384 · Food and Beverage: $1,390 · Education: $0.83.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $40,972.50 |
| Consulting Fee | $2,775.00 |
| Travel and Lodging | $2,383.95 |
| Food and Beverage | $1,389.59 |
| Education | $0.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $38,073.49 | 2021-2025 | Botox, Qulipta |
| Allergan, INC. | $30,878.80 | 2019-2022 | |
| Ipsen Biopharmaceuticals, INC | $20,316.69 | 2021-2025 | Dysport |
| Boston Scientific Corporation | $2,683.13 | 2019-2025 | General - Therapies, General - Dbs |
| Medtronic, INC. | $1,568.80 | 2021-2025 | Percept Pc Brainsense |
| Abbott Laboratories | $753.29 | 2023-2024 | Infinity |
| Mdd US Operations, LLC | $500.00 | 2020 | |
| Merz Pharmaceuticals, LLC | $269.33 | 2021 | |
| Csl Behring | $41.85 | 2021-2023 | Hizentra |
| Kyowa Kirin, INC. | $21.78 | 2021 | |
| Medtronic USA, INC. | $18.09 | 2019 | |
| Merz North America, INC. | $14.31 | 2020 | |
| Travere Therapeutics, INC. | $1.66 | 2022-2023 | Cholbam |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Echo Tan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.